Does it increase barriers to entry into the market? Examples include occupational licensure, the minimum wage, and restrictions on home businesses. Conversely, does it remove barriers to entry into the market?
The Center for Disease control defines TPPD as an extract of Mycobacterium tuberculosis, the bacteria that cause tuberculosis in humans. It is used to test if a person has been exposed to tuberculin protein, either from a previous tuberculosis vaccination, or from environmental exposure to the bacteria. There is no statute in current Idaho Code granting pharmacists the ability to prescribe TPPD, thus it is outside the pharmacist’s scope of practice. This bill will give pharmacists authority to prescribe TPPD with a doctor’s prescription. This bill makes medications more readily available, removing barriers to individuals suffering from illnesses associated with tuberculosis. (+1)
HB 0003 requires pharmacists meet a number of conditions. Pharmacists must complete a course on the proper “administration and interpretation of results from the United States Center for Disease Control or a comparable course from a provider accredited by the accreditation Council for Pharmacy.” The cost associated with the course requirement is an imposition on the pharmacist and on the free market. (-1)